MOLINA HEALTHCARE, INC. (MOH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 20B 40B 60B Q3 '21: 25.6B Q4 '21: 27.8B Q1 '22: 29B Q2 '22: 30.3B Q3 '22: 31.2B Q4 '22: 32B Q1 '23: 32.4B Q2 '23: 32.6B Q3 '23: 33.2B Q4 '23: 34.1B Q1 '24: 35.9B Q2 '24: 37.4B Q3 '24: 39.2B Q4 '24: 40.6B Q1 '25: 41.9B Q2 '25: 43.4B Q3 '25: 44.5B Q4 '25: 45.4B Q1 '26: 45.1B Q2 '26: 44.5B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 900M 1.8B 2.7B Q4 '15: 1.5B Q1 '16: 1.6B Q2 '16: 1.7B Q3 '16: 1.7B Q4 '16: 1.7B Q1 '17: 1.8B Q2 '17: 1.6B Q3 '17: 1.7B Q4 '17: 1.8B Q1 '18: 1.9B Q2 '18: 2.3B Q3 '18: 2.3B Q4 '18: 2.5B Q1 '19: 2.5B Q2 '19: 2.4B Q3 '19: 2.4B Q4 '19: 2.3B Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income TTM

0 600M 1.2B 1.8B Q4 '20: 1.1B Q1 '21: 1.1B Q2 '21: 988M Q3 '21: 920M Q4 '21: 1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.3B Q4 '22: 1.2B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.4B Q4 '23: 1.6B Q1 '24: 1.5B Q2 '24: 1.5B Q3 '24: 1.6B Q4 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.7B Q3 '25: 1.3B Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Net Income TTM

0 500M 1B 1.5B Q4 '20: 673M Q1 '21: 723M Q2 '21: 632M Q3 '21: 590M Q4 '21: 659M Q1 '22: 689M Q2 '22: 752M Q3 '22: 839M Q4 '22: 792M Q1 '23: 855M Q2 '23: 916M Q3 '23: 931M Q4 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.2B Q1 '25: 1.2B Q2 '25: 1.1B Q3 '25: 883M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Cost of Revenue TTM

0 15B 30B 45B Q3 '21: 21.8B Q4 '21: 23.7B Q1 '22: 24.8B Q2 '22: 25.8B Q3 '22: 26.5B Q4 '22: 27.2B Q1 '23: 27.5B Q2 '23: 27.6B Q3 '23: 28.2B Q4 '23: 28.7B Q1 '24: 30.2B Q2 '24: 31.5B Q3 '24: 32.9B Q4 '24: 34.4B Q1 '25: 35.5B Q2 '25: 37B Q3 '25: 38.4B Q4 '25: 39.5B Q1 '26: 39.3B Q2 '26: 38.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-1B 0 1B 2B 3B Q3 '19: 275M Q4 '19: 434M Q1 '20: 328M Q2 '20: 1B Q3 '20: 635M Q4 '20: 1.9B Q1 '21: 2.3B Q2 '21: 2.2B Q3 '21: 2.8B Q4 '21: 2.1B Q1 '22: 1.9B Q2 '22: 1.8B Q3 '22: 1.6B Q4 '24: 644M Q1 '25: 620M Q2 '25: 537M Q3 '25: -461M Q4 '25: -535M Q1 '26: 357M Q2 '26: 365M Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-1B 0 1B 2B 3B Q3 '19: 239M Q4 '19: 377M Q1 '20: 256M Q2 '20: 953M Q3 '20: 544M Q4 '20: 1.8B Q1 '21: 2.3B Q2 '21: 2.1B Q3 '21: 2.8B Q4 '21: 2B Q1 '22: 1.8B Q2 '22: 1.7B Q3 '22: 1.5B Q4 '24: 544M Q1 '25: 525M Q2 '25: 427M Q3 '25: -574M Q4 '25: -636M Q1 '26: 251M Q2 '26: 271M Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '20: 61M Q2 '20: 59.4M Q3 '20: 59.6M Q1 '21: 58.6M Q2 '21: 58.4M Q3 '21: 58.5M Q1 '22: 58.7M Q2 '22: 58.4M Q3 '22: 58.3M Q1 '23: 58M Q2 '23: 57.9M Q3 '23: 58.1M Q1 '24: 58.3M Q2 '24: 58.2M Q3 '24: 57.7M Q1 '25: 54.8M Q2 '25: 53.7M Q3 '25: 52.5M Q1 '26: 51M Q2 '26: 51.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 8.00 16.00 24.00 Q4 '20: 11.25 Q1 '21: 12.22 Q2 '21: 10.73 Q3 '21: 10.09 Q4 '21: 11.25 Q1 '22: 11.75 Q2 '22: 12.84 Q3 '22: 14.33 Q4 '22: 13.56 Q1 '23: 14.69 Q2 '23: 15.79 Q3 '23: 16.05 Q4 '23: 18.77 Q1 '24: 18.42 Q2 '24: 18.24 Q3 '24: 19.68 Q4 '24: 20.44 Q1 '25: 20.72 Q2 '25: 20.30 Q3 '25: 16.16 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.